These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 28511329

  • 1. [Therapeutic effect of combined use of FGF1-loaded nano-liposomes and ultrasound-targeted microbubble destruction technique on treating rats with experimental diabetic cardiomyopathy].
    Zhang M, Zhao YZ, Ma WC, Xu JL, Wang JL, Chen MJ, Yu L, Chen YN.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May 24; 45(5):427-433. PubMed ID: 28511329
    [Abstract] [Full Text] [Related]

  • 2. Advanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique.
    Zhang M, Yu WZ, Shen XT, Xiang Q, Xu J, Yang JJ, Chen PP, Fan ZL, Xiao J, Zhao YZ, Lu CT.
    Cardiovasc Drugs Ther; 2016 Jun 24; 30(3):247-61. PubMed ID: 26947349
    [Abstract] [Full Text] [Related]

  • 3. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique.
    Zhao YZ, Zhang M, Wong HL, Tian XQ, Zheng L, Yu XC, Tian FR, Mao KL, Fan ZL, Chen PP, Li XK, Lu CT.
    J Control Release; 2016 Feb 10; 223():11-21. PubMed ID: 26712588
    [Abstract] [Full Text] [Related]

  • 4. Using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy.
    Zhao YZ, Zhang M, Tian XQ, Zheng L, Lu CT.
    Int J Nanomedicine; 2016 Feb 10; 11():675-86. PubMed ID: 26937188
    [Abstract] [Full Text] [Related]

  • 5. Functional and pathological improvements of the hearts in diabetes model by the combined therapy of bFGF-loaded nanoparticles with ultrasound-targeted microbubble destruction.
    Zhao YZ, Tian XQ, Zhang M, Cai L, Ru A, Shen XT, Jiang X, Jin RR, Zheng L, Hawkins K, Charkrabarti S, Li XK, Lin Q, Yu WZ, Ge S, Lu CT, Wong HL.
    J Control Release; 2014 Jul 28; 186():22-31. PubMed ID: 24815422
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the Preventive Effect Against Diabetic Cardiomyopathy of FGF1-Loaded Nanoliposomes Combined With Microbubble Cavitation by Ultrasound.
    Zheng L, Shen CL, Li JM, Ma YL, Yan N, Tian XQ, Zhao YZ.
    Front Pharmacol; 2019 Jul 28; 10():1535. PubMed ID: 31998132
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment with ultrasound-targeted microbubble destruction technique and NM-aFGF-loaded PEG-nanoliposomes protects against diabetic cardiomyopathy-induced oxidative stress by activating the AKT/GSK-3β1/Nrf-2 pathway.
    Zhang M, Zhu NW, Ma WC, Chen MJ, Zheng L.
    Drug Deliv; 2020 Dec 28; 27(1):938-952. PubMed ID: 32611270
    [Abstract] [Full Text] [Related]

  • 8. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
    Tian XQ, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, Lu CT, Yuan JJ, Zhao YZ.
    Int J Nanomedicine; 2017 Dec 28; 12():7103-7119. PubMed ID: 29026304
    [Abstract] [Full Text] [Related]

  • 9. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y, Zhang W, Zhong M, Ma X, Qi TG, Sun H.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):366-70. PubMed ID: 17456374
    [Abstract] [Full Text] [Related]

  • 10. Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy.
    Yue T, Xu HL, Chen PP, Zheng L, Huang Q, Sheng WS, Zhuang YD, Jiao LZ, Chi TT, ZhuGe DL, Liu JJ, Zhao YZ, Lan L.
    Int J Pharm; 2017 Aug 07; 528(1-2):664-674. PubMed ID: 28642201
    [Abstract] [Full Text] [Related]

  • 11. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M, Zhang Y, Miao Y, Li L, Gong HP, Ma X, Sun H, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):232-6. PubMed ID: 16677501
    [Abstract] [Full Text] [Related]

  • 12. Ultrasound-targeted microbubble destruction promotes myocardial angiogenesis and functional improvements in rat model of diabetic cardiomyopathy.
    Zhang X, Tian X, Li P, Zhu H, Zhou N, Fang Z, Yang Y, Jing Y, Yuan J.
    BMC Cardiovasc Disord; 2021 Jan 07; 21(1):21. PubMed ID: 33413110
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy].
    Liu HZ, Gao CY, Wang XQ, Fu HX, Yang HH, Wang XP, Liu YH, Li MW, Niu ZM, Dai GY, Qi DT, Zhang Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar 07; 40(3):219-24. PubMed ID: 22801267
    [Abstract] [Full Text] [Related]

  • 17. Ultrasound-targeted semaglutide-loaded PEG-nanoliposomes microbubble destruction protects diabetic cardiomyopathy by activating PI3K/Akt/Nrf2 signaling pathway.
    Zhu J, Wang H, Yan C, Li B, Chen B.
    Heliyon; 2023 Sep 07; 9(9):e19873. PubMed ID: 37809373
    [Abstract] [Full Text] [Related]

  • 18. [Effects of yellow wine polyphenols on cardiomyocyte apoptosis in diabetic cardiomyopathy rats].
    Pan SL, Lin H, Luo HQ, Gao FD, Meng LP, Guo Y, Guo HY, Chi JF.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May 08; 33(5):431-435. PubMed ID: 29926588
    [Abstract] [Full Text] [Related]

  • 19. The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats.
    Ge M, Ma S, Tao L, Guan S.
    Am J Chin Med; 2009 May 08; 37(6):1059-68. PubMed ID: 19938216
    [Abstract] [Full Text] [Related]

  • 20. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y, Sharma SS.
    Cardiovasc Drugs Ther; 2017 Jun 08; 31(3):255-267. PubMed ID: 28695302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.